81 related articles for article (PubMed ID: 580196)
1. Major pharmacological effects of 6-methoxytetrahydro-beta-carboline, a drug elevating the tissue 5-hydroxytryptamine level.
Airaksinen MM; Ho BT; An R; Taylor D
Arzneimittelforschung; 1978; 28(1):42-6. PubMed ID: 580196
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-carbolines of plasma corticosterone in mice.
Meyer JS; Buckholtz NS
Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):205-13. PubMed ID: 1085012
[TBL] [Abstract][Full Text] [Related]
3. [To the pharmacology of N-substituted 2,3-dihydroindoles].
Arnol'dova KA; Komissarov IV; Sheĭnkman AK
Farmakol Toksikol; 1966; 29(6):721-5. PubMed ID: 6000369
[No Abstract] [Full Text] [Related]
4. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro -beta-carbolin-1-one (B-193).
Wiczyńska B; Chojnacka-Wójcik E; Rokosz-Pelc A; Mazela H; Przegaliński E
Pol J Pharmacol Pharm; 1989; 41(2):169-81. PubMed ID: 2556691
[TBL] [Abstract][Full Text] [Related]
5. Effects of 6-methoxytetrahydro-beta-carboline on 5-hydroxytryptamine binding in rat brain.
Taylor DL; Silverman PB; Ho BT
J Pharm Pharmacol; 1984 Feb; 36(2):125-7. PubMed ID: 6143800
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological properties of some homologues of 5-methoxytryptamine].
Arutiunian GS
Farmakol Toksikol; 1967; 30(2):174-8. PubMed ID: 5628514
[No Abstract] [Full Text] [Related]
7. beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects.
Airaksinen MM; Kari I
Med Biol; 1981 Aug; 59(4):190-211. PubMed ID: 6121956
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
[TBL] [Abstract][Full Text] [Related]
9. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
[TBL] [Abstract][Full Text] [Related]
10. The uptake of 6-methoxy-1,2,3,4-tetrahydro-beta-carboline and its effect on 5-hydroxytryptamine uptake and release in blood platelets.
Airaksinen MM; Huang JT; Ho BT; Taylor D; Walker K
Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):375-80. PubMed ID: 726902
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines.
Misztal S; Boksa J; Chojnacka-Wójcik E; Tatarczyńska E; Lewandowska A
Pol J Pharmacol Pharm; 1987; 39(1):97-103. PubMed ID: 3499603
[TBL] [Abstract][Full Text] [Related]
12. Preliminary report on the pharmacology of i-ethyl-B-carboline [proceedings].
Bamgbose SO; Dramane K
West Afr J Pharmacol Drug Res; 1976 Jun; 3(1):84P-85P. PubMed ID: 1023521
[No Abstract] [Full Text] [Related]
13. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
Fanelli O; Mazzoncini V; Trallori L
Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
[No Abstract] [Full Text] [Related]
15. Synthesis and pharmacological properties of 9-(N, N-dimethylaminopropyl)-1,2,3,4-tetrahydro-beta-carbolines.
Misztal S; Wiertek J; Michaluk J
Pol J Pharmacol Pharm; 1977; 29(6):675-82. PubMed ID: 600866
[TBL] [Abstract][Full Text] [Related]
16. Some pharmacological properties and cumulative, subchronic and chronic toxicity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)] -1,2,3,4-tetrahydro-beta-carbolin-1-one (B-193).
Sieklucka-Dziuba M; Rajtar G; Kleinrok Z
Pol J Pharmacol; 1995; 47(4):305-11. PubMed ID: 8616509
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary pharmacologic studies on 1-(4-pyridyl)- and 6-methoxy-1-(4-pyridyl)-beta-carboline.
Wiertek J; Michaluk J
Arch Immunol Ther Exp (Warsz); 1975; 23(4):581-7. PubMed ID: 1164158
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two distinctive beta-carbolines on serotonin binding in human platelets.
Taylor DL; Tansey W; Cook JM; Ho BT
Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):133-6. PubMed ID: 3983465
[TBL] [Abstract][Full Text] [Related]
19. Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.
Audia JE; Evrard DA; Murdoch GR; Droste JJ; Nissen JS; Schenck KW; Fludzinski P; Lucaites VL; Nelson DL; Cohen ML
J Med Chem; 1996 Jul; 39(14):2773-80. PubMed ID: 8709108
[TBL] [Abstract][Full Text] [Related]
20. Central action of 6-hydroxytryptamine in rats.
Jamrozik-Kruk Z; Brus R
Acta Physiol Pol; 1980; 31(3):253-60. PubMed ID: 6160727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
